VIVS VivoSim Labs Inc Projected Price to Earnings

The forward P/E chart for VivoSim Labs Inc (VIVS) demonstrates a high dependency on the narrow 3D bioprinting segment, which creates significant risks. VivoSim Labs Inc (VIVS) dominates pricing power through the creation of living organ models, yet faces pressure from emerging biotech startups. The 0.00 mark indicates the level of current investor expectations regarding the issuer's future earnings.

VIVS - Organovo Holdings, Inc. Market Cap to Projected Earnings over the range 04/25/2025 - 11/15/2026

Financial and market metric breakdowns for Organovo Holdings (VIVS)

- stock value and consensus price forecast:

Price Chart organovo.com|VIVS - Analyst Median Target

- market capitalization data:

Market Valuation Organovo Holdings, Inc.|VIVS - Aggregate Business Value

- issuer book value statistics:

Book Value per Share Organovo|VIVS - Book Valuation of Business|Market Capitalization to Book Value Ratio organovo.com|VIVS - Cumulative Company Assets

- debt and solvency information:

- earnings and market ratios statistics:

VIVS - Net Financial Result|Projected Future Earnings VivoSim Labs Inc|VIVS - Price to Earnings Ratio|Forward P/E Multiple VivoSim Labs|VIVS - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization VivoSim Labs|VIVS - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Organovo|VIVS - Earnings per share for the trailing year|Quarterly EPS earnings growth organovo.com|VIVS - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year VivoSim Labs Inc

- revenue and sales proceeds data:

VIVS - Company Total Sales Volume|Company Future Sales Volume Organovo|VIVS - P/S Multiple|Forward P/S Multiple Organovo Holdings|VIVS - Annual Revenue Growth (Last Twelve Months)

Fundamental company analysis:Organovo

Forward P/E determines the market value of a share relative to expected earnings, accounting for resource and labor cost inflation to assess whether an asset is overvalued or undervalued. By analyzing the forward P/E level of VivoSim Labs Inc. (VIVS), an investor can see the impact of long-term B2B contracts on future cash flows, where stable demand for 3D bioprinting of tissues ensures high margins and fundamental business resilience.

Competitors of VivoSim Labs Inc (VIVS)